Cargando…
Acquired Hemophilia A and ST-Elevation Myocardial Infarction (STEMI): A Rare Presentation and Management Dilemma
Thrombotic events are a rare complication of recombinant activated factor VII (rFVIIa) therapy in patients with hemophilia. We present a case of a 71-year-old male who developed ST-elevation myocardial infarction after receiving rFVIIa replacement therapy for acquired hemophilia A.
Autores principales: | Yabut, Jevin, Lima, Gian, Vankina, Ritika, Kumar, Swarup, Meng, Joyce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241663/ https://www.ncbi.nlm.nih.gov/pubmed/37288205 http://dx.doi.org/10.7759/cureus.38549 |
Ejemplares similares
-
COVID-19 Pneumonia: ST-segment Elevation Myocardial Infarction (STEMI) and Myocarditis
por: Ali, Azhar, et al.
Publicado: (2020) -
Recurrent ST-Elevation Myocardial Infarction (STEMI) in Coronary Artery Aneurysm Secondary to Atherosclerosis
por: Bhuiyan, Md, et al.
Publicado: (2022) -
Shark Fin Electrocardiogram: A Deadly Electrocardiogram Pattern in ST-Elevation Myocardial Infarction (STEMI)
por: Jaiswal, Amit K, et al.
Publicado: (2021) -
Clinical Features of the Aslanger Pattern to Compensate for the Limitation of ST-Elevation Myocardial Infarction (STEMI) Criteria
por: Miyauchi, Eiji, et al.
Publicado: (2023) -
Eptifibatide-Induced Severe Thrombocytopenia After ST-Elevation Myocardial Infarction (STEMI): A Case Report
por: Gheith, Zaid, et al.
Publicado: (2022)